References
1. Gillessen, A., & Schmidt, H. H. J. (2020). Silymarin as supportive treatment in liver diseases: A narrative review. Advances in therapy, 37(4), 1279-1301.
https://link.springer.com/article/10.1007/s12325-020-01251-y
2. Abenavoli, L., & Milic, N. (2017). Silymarin for liver disease. In Liver Pathophysiology (pp. 621-631). Academic Press.
https://www.sciencedirect.com/science/article/pii/B978012804274800045X
3. Alavinejad, P., Farsi, F., Husain, D., & Rezazadeh, A. (2021). The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a
randomized double blind clinical trial. Diabetology & Metabolic Syndrome, 13(1), 1-9
https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-021-00731-7
4. Bauman, E., & Moorthy, S. (2018). Turmeric: a natural anti-inflammatory tonic. THE JOURNAL, 26(2).
https://www.namahjournal.com/doc/Actual/Turmeric-a-natural-anti-inflammatory-tonic-vol-26-iss-1.html
5. Mahboubi, M., & Mahboubi, M. (2020). Hepatoprotection by dandelion (Taraxacum officinale) and mechanisms. Asian Pacific Journal of Tropical Biomedicine, 10(1), 1.
https://www.apjtb.org/article.asp?issn=2221-1691;year=2020;volume=10;issue=1;spage=1;epage=10;aulast=Mahboubi
6. Kour, J., Sharma, R., Nayik, G. A., Ramaiyan, B., Sofi, S. A., Alam, M. S., & Anand, N. (2020). Dandelion. In Antioxidants in Vegetables and Nuts-Properties and Health Benefits (pp. 237-248). Springer, Singapore.
https://link.springer.com/chapter/10.1007/978-981-15-7470-2_12
7. Raj, P. V., Nitesh, K., Chandrashekhar, H. R., Mallikarjuna Rao, C., Venkata Rao, J., & Udupa, N. (2010). Effect of Lecithin and silymarin on D-galactosamine induced toxicity in isolated hepatocytes and rats.
Indian Journal of Clinical Biochemistry, 25(2), 169-174.
https://link.springer.com/article/10.1007/s12291-010-0031-0